Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 57

1.

Clinical and economic impact of generic versus brand name meropenem use in an intensive care unit in Colombia.

Ordóñez K, Feinstein MM, Reyes S, Hernández-Gómez C, Pallares C, Villegas MV.

Braz J Infect Dis. 2019 Jul - Aug;23(4):237-245. doi: 10.1016/j.bjid.2019.06.010. Epub 2019 Jul 22.

2.

Detection of carbapenemase-producing Pseudomonas aeruginosa: Evaluation of the carbapenem inactivation method (CIM).

Gutiérrez S, Correa A, Hernández-Gómez C, De La Cadena E, Pallares C, Villegas MV.

Enferm Infecc Microbiol Clin. 2019 Dec;37(10):648-651. doi: 10.1016/j.eimc.2019.02.004. Epub 2019 Mar 18. English, Spanish.

PMID:
30898368
3.

Clinical Indicators of Fatal Dengue in Two Endemic Areas of Colombia: A Hospital-Based Case-Control Study.

Rojas EM, Herrera VM, Miranda MC, Rojas DP, Gómez AM, Pallares C, Cobos SM, Pardo L, Gélvez M, Páez A, Mantilla JC, Bonelo A, Parra E, Villar LA.

Am J Trop Med Hyg. 2019 Feb;100(2):411-419. doi: 10.4269/ajtmh.17-0323.

PMID:
30652671
4.

Performance of the OraQuick Hepatitis C virus antibody test in oral fluid and fingerstick blood before and after treatment-induced viral clearance.

Pallarés C, Carvalho-Gomes Â, Hontangas V, Conde I, Di Maira T, Aguilera V, Benlloch S, Berenguer M, López-Labrador FX.

J Clin Virol. 2018 May;102:77-83. doi: 10.1016/j.jcv.2018.02.016. Epub 2018 Feb 24.

PMID:
29525634
5.

Cytomegalovirus reactivation in liver transplant recipients due to hepatitis C cirrhosis is associated with higher cardiovascular risk - an observational, retrospective study.

Aguilera V, Di Maira T, Conde I, Fornés-Ferrer V, Vinaixa C, Pallarés C, Carvalho-Gomes A, Cubells A, García M, Rubín Á, Benlloch S, Gonzalez-Dieguez L, Molina JM, Puchades L, López-Labrador FX, Prieto M, Berenguer M.

Transpl Int. 2018 Jun;31(6):649-657. doi: 10.1111/tri.13145. Epub 2018 Mar 26.

6.

Molecular characterisation of carbapenem-resistant Enterobacter cloacae complex in Colombia: blaKPC and the 'changing landscape'.

De La Cadena E, Correa A, Muñoz JS, Rojas LJ, Hernández-Gómez C, Pallares C, Perez F, Bonomo RA, Villegas MV.

J Glob Antimicrob Resist. 2018 Jun;13:184-189. doi: 10.1016/j.jgar.2017.12.008. Epub 2017 Dec 20.

PMID:
29274468
7.

Is Traffic Still an Important Emitter of Monoaromatic Organic Compounds in European Urban Areas?

Borbon A, Boynard A, Salameh T, Baudic A, Gros V, Gauduin J, Perrussel O, Pallares C.

Environ Sci Technol. 2018 Jan 16;52(2):513-521. doi: 10.1021/acs.est.7b01408. Epub 2017 Dec 26.

PMID:
29164867
8.

[Impact of rational use of antibiotics in a third level clinic in Colombia].

Pallares CJ, Cataño JC.

Rev Chilena Infectol. 2017 Jun;34(3):205-211. doi: 10.4067/S0716-10182017000300001. Spanish.

9.

Distinct Genetic Diversity of Carbapenem-Resistant Acinetobacter baumannii from Colombian Hospitals.

Correa A, Del Campo R, Escandón-Vargas K, Perenguez M, Rodríguez-Baños M, Hernández-Gómez C, Pallares C, Perez F, Arias CA, Cantón R, Villegas MV.

Microb Drug Resist. 2018 Jan/Feb;24(1):48-54. doi: 10.1089/mdr.2016.0190. Epub 2017 Jun 1.

10.

Improved Outcomes When Antibiotic Prescribing Guidelines Are Followed by Healthcare Providers: A Colombian Example to Encourage Adherence in Hospital Settings.

Feinstein MM, Escandón-Vargas K, Reyes S, Hernández-Gómez C, Pallares CJ, Villegas MV.

Infect Control Hosp Epidemiol. 2017 Jun;38(6):756-758. doi: 10.1017/ice.2017.45. Epub 2017 Apr 3. No abstract available. Erratum in: Infect Control Hosp Epidemiol. 2018 Jul;39(7):893.

PMID:
28366177
11.

Epidemiology of Candida isolates from Intensive Care Units in Colombia from 2010 to 2013.

Motoa G, Muñoz JS, Oñate J, Pallares CJ, Hernández C, Villegas MV.

Rev Iberoam Micol. 2017 Jan - Mar;34(1):17-22. doi: 10.1016/j.riam.2016.02.006. Epub 2016 Oct 31.

PMID:
27810262
12.

[Prevalence and risk factors for extended-spectrum β-lactamase-producing Escherichia coli causing community-onset urinary tract infections in Colombia].

Blanco VM, Maya JJ, Correa A, Perenguez M, Muñoz JS, Motoa G, Pallares CJ, Rosso F, Matta L, Celis Y, Garzon M, Villegas MV.

Enferm Infecc Microbiol Clin. 2016 Nov;34(9):559-565. doi: 10.1016/j.eimc.2015.11.017. Epub 2016 Jan 13. Spanish.

13.

Combinatory effect of BRCA1 and HERC2 expression on outcome in advanced non-small-cell lung cancer.

Bonanno L, Costa C, Majem M, Sanchez JJ, Rodriguez I, Gimenez-Capitan A, Molina-Vila MA, Vergnenegre A, Massuti B, Favaretto A, Rugge M, Pallares C, Taron M, Rosell R.

BMC Cancer. 2016 May 14;16:312. doi: 10.1186/s12885-016-2339-5.

14.

Characterization and Clinical Impact of Bloodstream Infection Caused by Carbapenemase-Producing Enterobacteriaceae in Seven Latin American Countries.

Villegas MV, Pallares CJ, Escandón-Vargas K, Hernández-Gómez C, Correa A, Álvarez C, Rosso F, Matta L, Luna C, Zurita J, Mejía-Villatoro C, Rodríguez-Noriega E, Seas C, Cortesía M, Guzmán-Suárez A, Guzmán-Blanco M.

PLoS One. 2016 Apr 22;11(4):e0154092. doi: 10.1371/journal.pone.0154092. eCollection 2016.

15.

Integrating Behavioral Health and Primary Care: Consulting, Coordinating and Collaborating Among Professionals.

Cohen DJ, Davis M, Balasubramanian BA, Gunn R, Hall J, deGruy FV 3rd, Peek CJ, Green LA, Stange KC, Pallares C, Levy S, Pollack D, Miller BF.

J Am Board Fam Med. 2015 Sep-Oct;28 Suppl 1:S21-31. doi: 10.3122/jabfm.2015.S1.150042.

16.

[Letters to the editor].

Pallares CJ, Martínez E.

Biomedica. 2015 Jan-Mar;35(1):146-53. doi: 10.1590/S0120-41572015000100020. Spanish. No abstract available.

PMID:
26148046
17.

Pharmacogenetics of the DNA repair pathways in advanced non-small cell lung cancer patients treated with platinum-based chemotherapy.

Sullivan I, Salazar J, Majem M, Pallarés C, Del Río E, Páez D, Baiget M, Barnadas A.

Cancer Lett. 2014 Oct 28;353(2):160-6. doi: 10.1016/j.canlet.2014.07.023. Epub 2014 Jul 25.

PMID:
25069034
18.

[Mortality risk factors associated with healthcare infections in a tertiary level university hospital in Colombia].

Pallares CJ, Martínez E.

Biomedica. 2014 Apr;34 Suppl 1:148-55. doi: 10.1590/S0120-41572014000500017. Spanish.

PMID:
24968046
19.

The predictive value of 53BP1 and BRCA1 mRNA expression in advanced non-small-cell lung cancer patients treated with first-line platinum-based chemotherapy.

Bonanno L, Costa C, Majem M, Sanchez JJ, Gimenez-Capitan A, Rodriguez I, Vergnenegre A, Massuti B, Favaretto A, Rugge M, Pallares C, Taron M, Rosell R.

Oncotarget. 2013 Oct;4(10):1572-81.

20.

An update on molecularly targeted therapies in second- and third-line treatment in non-small cell lung cancer: focus on EGFR inhibitors and anti-angiogenic agents.

Majem M, Pallarès C.

Clin Transl Oncol. 2013 May;15(5):343-57. doi: 10.1007/s12094-012-0964-2. Epub 2013 Jan 29. Review.

PMID:
23359171
21.

Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial.

Rosell R, Carcereny E, Gervais R, Vergnenegre A, Massuti B, Felip E, Palmero R, Garcia-Gomez R, Pallares C, Sanchez JM, Porta R, Cobo M, Garrido P, Longo F, Moran T, Insa A, De Marinis F, Corre R, Bover I, Illiano A, Dansin E, de Castro J, Milella M, Reguart N, Altavilla G, Jimenez U, Provencio M, Moreno MA, Terrasa J, Muñoz-Langa J, Valdivia J, Isla D, Domine M, Molinier O, Mazieres J, Baize N, Garcia-Campelo R, Robinet G, Rodriguez-Abreu D, Lopez-Vivanco G, Gebbia V, Ferrera-Delgado L, Bombaron P, Bernabe R, Bearz A, Artal A, Cortesi E, Rolfo C, Sanchez-Ronco M, Drozdowskyj A, Queralt C, de Aguirre I, Ramirez JL, Sanchez JJ, Molina MA, Taron M, Paz-Ares L; Spanish Lung Cancer Group in collaboration with Groupe Français de Pneumo-Cancérologie and Associazione Italiana Oncologia Toracica.

Lancet Oncol. 2012 Mar;13(3):239-46. doi: 10.1016/S1470-2045(11)70393-X. Epub 2012 Jan 26.

PMID:
22285168
22.

Phase II study of continuous daily sunitinib dosing in patients with previously treated advanced non-small cell lung cancer.

Novello S, Scagliotti GV, Rosell R, Socinski MA, Brahmer J, Atkins J, Pallares C, Burgess R, Tye L, Selaru P, Wang E, Chao R, Govindan R.

Br J Cancer. 2009 Nov 3;101(9):1543-8. doi: 10.1038/sj.bjc.6605346. Epub 2009 Oct 13.

23.

Multicenter, phase II trial of sunitinib in previously treated, advanced non-small-cell lung cancer.

Socinski MA, Novello S, Brahmer JR, Rosell R, Sanchez JM, Belani CP, Govindan R, Atkins JN, Gillenwater HH, Pallares C, Tye L, Selaru P, Chao RC, Scagliotti GV.

J Clin Oncol. 2008 Feb 1;26(4):650-6. doi: 10.1200/JCO.2007.13.9303.

24.

[Clinical utility of attenuation correction with X-rays in myocardial perfusion SPECT studies].

Bajén MT, Ricart Y, Rodríguez-Gasén A, Mora J, Quintana ME, Benítez A, Domènech A, Ruiz-Mayoral A, Puchal R, Pallarés C, Martín-Comín J.

Rev Esp Med Nucl. 2007 Nov-Dec;26(6):359-66. Spanish.

PMID:
18021690
25.

Induction chemotherapy with paclitaxel plus carboplatin followed by paclitaxel with concurrent radiotherapy in stage IIIB non-small-cell lung cancer (NSCLC) patients: a phase II trial.

Pallarés C, Capdevila J, Paredes A, Farré N, Ciria JP, Membrive I, Basterrechea L, Gomez-Segura G, Barnadas A.

Lung Cancer. 2007 Nov;58(2):238-45. Epub 2007 Jul 20.

PMID:
17658655
26.

Description and management of cutaneous side effects during cetuximab or erlotinib treatments: a prospective study of 30 patients.

Roé E, García Muret MP, Marcuello E, Capdevila J, Pallarés C, Alomar A.

J Am Acad Dermatol. 2006 Sep;55(3):429-37. Epub 2006 Jul 13.

PMID:
16908348
27.

Phase III study comparing cisplatin plus fluorouracil to paclitaxel, cisplatin, and fluorouracil induction chemotherapy followed by chemoradiotherapy in locally advanced head and neck cancer.

Hitt R, López-Pousa A, Martínez-Trufero J, Escrig V, Carles J, Rizo A, Isla D, Vega ME, Martí JL, Lobo F, Pastor P, Valentí V, Belón J, Sánchez MA, Chaib C, Pallarés C, Antón A, Cervantes A, Paz-Ares L, Cortés-Funes H.

J Clin Oncol. 2005 Dec 1;23(34):8636-45. Epub 2005 Nov 7. Erratum in: J Clin Oncol. 2006 Feb 20;24(6):1015.

PMID:
16275937
28.

Medical speciality and pattern of medicines prescription.

Vallano A, Montané E, Arnau JM, Vidal X, Pallarés C, Coll M, Laporte JR.

Eur J Clin Pharmacol. 2004 Dec;60(10):725-30. Epub 2004 Oct 16.

PMID:
15502994
29.

[Secondary Preventive Program of atherosclerosis in a university hospital. Results and predictors of clinical course].

Pintó X, Meco JF, Corbella E, Figueras R, Pallarés C, Esplugas E, Castiñeiras MJ, Marrugat J, Pujol R.

Med Clin (Barc). 2003 May 31;120(20):768-72. Spanish.

PMID:
12797928
30.

The role of anxiety and adaptation to illness in the intensity of postchemotherapy nausea in cancer patients.

Blasco T, Pallarés C, Alonso C, López López JJ.

Span J Psychol. 2000 May;3(1):47-52.

PMID:
11761740
32.

Synthesis of aryl 3-O-beta-cellobiosyl-beta-D-glucopyranosides for reactivity studies of 1,3-1,4-beta-glucanases.

Planas A, Abel M, Millet O, Palasí J, Pallarés C, Viladot JL.

Carbohydr Res. 1998 Aug;310(1-2):53-64.

PMID:
9794071
33.

Cardiovascular risk factors associated with clinically isolated and diffuse atherosclerosis in Spanish patients with coronary artery disease.

Meco JF, Pintó X, Escribà JM, Vela M, Jara F, Pallarés C, Castiñeiras MJ, Pujol R.

Eur J Clin Invest. 1998 Aug;28(8):643-50.

PMID:
9767359
34.

[Improvement in diastolic function in hypertensive patients with left ventricular hypertrophy with inhibitors of the angiotensin converting enzyme].

Sagastagoitia JD, Morillas M, Martínez A, Lage E, Pallarés C, Ugartemendía C, Asín E, Barrios V, Julia J, Sánchez P, Calvo C, González J, Piña C, García-Barbal J, Arnau C.

Rev Clin Esp. 1998 Jan;198(1):15-22. Spanish.

PMID:
9580230
35.

Vegetable and fruit intake and the risk of lung cancer in women in Barcelona, Spain.

Agudo A, Esteve MG, Pallarés C, Martínez-Ballarín I, Fabregat X, Malats N, Machengs I, Badia A, González CA.

Eur J Cancer. 1997 Jul;33(8):1256-61.

PMID:
9301452
36.

[Malignant pleural mesothelioma: clinical characteristics, prognostic factors and treatment].

Mesía R, Pallares C, Mendoza L, Bellet M, Vega M, León C, López López JJ.

Arch Bronconeumol. 1995 Nov;31(9):455-9. Spanish.

PMID:
8520817
37.

Lung cancer and cigarette smoking in women: a case-control study in Barcelona (Spain).

Agudo A, Barnadas A, Pallares C, Martinez I, Fabregat X, Rosello J, Estape J, Planas J, Gonzalez CA.

Int J Cancer. 1994 Oct 15;59(2):165-9.

PMID:
7927913
38.

CHOP chemotherapy of intermediate and high-grade non-Hodgkin's lymphoma.

Llanos M, Tabernero J, Brunet J, Amenedo M, Pallares C, de Andres L, Lopez JJ.

Acta Oncol. 1994;33(8):935-9.

PMID:
7818928
39.

Ovarian carcinoma preceded by cerebral metastasis: review of the literature.

Izquierdo MA, Ojeda B, Pallarés C, Alonso MC, Matias-Guiu X.

Gynecol Oncol. 1992 May;45(2):206-10. Review.

PMID:
1592289
40.

A phase II trial of carboplatin in untreated patients with extensive stage small cell lung cancer.

Pallares C, Izquierdo MA, Paredes A, Fernandez Sagarra A, De Andrés L, López López JJ.

Cancer. 1991 Jul 1;68(1):40-3.

PMID:
1646684
41.

[Superior vena cava syndrome as manifestation of adenocarcinoma of the pancreas].

Sola C, Paredes A, Villanueva C, Pallarés C.

An Med Interna. 1989 May;6(5):278-9. Spanish. No abstract available.

PMID:
2491548
42.

Cisplatin and intravenous continuous infusion of bleomycin in advanced and metastatic esophageal cancer.

Marcuello E, Alba E, Gómez de Segura G, Sánchez Parra M, de Andrés L, López Pousa A, Pallares C, Germá JR, López López JJ.

Eur J Cancer Clin Oncol. 1988 Apr;24(4):633-5.

PMID:
2454822
43.

Long-term survival in small cell carcinoma of the lung.

Pallares C, Bastus R, Lopez JJ, De Andres L.

Eur J Cancer Clin Oncol. 1987 May;23(5):541-4. Erratum in: Eur J Cancer Clin Oncol 1987 Aug;23(8):1256.

PMID:
2820739
44.

[Cardiac catheterization and femoral percutaneous coronarography as outpatient procedures].

Cequier A, Esplugas E, Pérez Ayuso MJ, Jara F, Pallarés C.

Rev Esp Cardiol. 1986 May-Jun;39(3):184-7. Spanish. No abstract available.

PMID:
3738102
45.

Phase II trial of chemotherapy with cisplatin and etoposide in non-small cell lung cancer.

Pallares C, Piera JM, Barnadas A, Izquierdo A, Lopez Lopez JJ.

Cancer Treat Rep. 1986 May;70(5):677. No abstract available.

PMID:
3708618
46.

[Value of T-lymphocyte subpopulations in dilated myocardiopathy].

Pallarés C, Blanchs L, Gausí C, Buendía E.

Med Clin (Barc). 1985 Mar 2;84(8):336-7. Spanish. No abstract available.

PMID:
3872390
47.

[Superior vena cava syndrome: an infrequent complication of acute aortic dissection].

Cequier A, Pallarés C, Esplugas E, Gausí C.

Med Clin (Barc). 1985 Feb 16;84(6):252. Spanish. No abstract available.

PMID:
3982140
48.

[Percutaneous transluminal coronary angioplasty. Initial experience with the steerable technic at the Hospital Bellvitge-Princeps d'Espanya ].

Esplugas E, Cequier A, Jara F, Pallarés C, Castells E.

Rev Esp Cardiol. 1985;38 Suppl 1:21-4. Spanish. No abstract available.

PMID:
2930873
49.

[Optimal projections in selective aortocoronary graft radiography].

Esplugas E, Jara F, Pallarés C, Castells E, Saura E, Pérez Ayuso MJ.

Rev Esp Cardiol. 1984 Jul-Aug;37(4):236-9. Spanish. No abstract available.

PMID:
6332352
50.

[A new pre-shaped catheter for aortic valve stenosis].

Esplugas E, Jara F, Pallarés C, Pérez Ayuso MJ.

Rev Esp Cardiol. 1984 Mar-Apr;37(2):94-8. Spanish. No abstract available.

PMID:
6463325

Supplemental Content

Loading ...
Support Center